These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3923267

  • 1. A possible beneficial effect of metronidazole in reducing TPN-associated liver function derangements.
    Freund HR, Muggia-Sullam M, LaFrance R, Enrione EB, Popp MB, Bjornson HS.
    J Surg Res; 1985 Apr; 38(4):356-63. PubMed ID: 3923267
    [Abstract] [Full Text] [Related]

  • 2. Metronidazole in prevention of cholestasis associated with total parenteral nutrition.
    Capron JP, Gineston JL, Herve MA, Braillon A.
    Lancet; 1983 Feb 26; 1(8322):446-7. PubMed ID: 6131169
    [Abstract] [Full Text] [Related]

  • 3. Metronidazole prevention of serum liver enzyme abnormalities during total parenteral nutrition.
    Lambert JR, Thomas SM.
    JPEN J Parenter Enteral Nutr; 1985 Feb 26; 9(4):501-3. PubMed ID: 2863398
    [Abstract] [Full Text] [Related]

  • 4. The effect of metronidazole on TPN-associated liver dysfunction in neonates.
    Kubota A, Okada A, Imura K, Kawahara H, Nezu R, Kamata S, Takagi Y.
    J Pediatr Surg; 1990 Jun 26; 25(6):618-21. PubMed ID: 2113577
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of hepatic steatosis in the parenterally fed rat.
    Hall RI, Grant JP, Ross LH, Coleman RA, Bozovic MG, Quarfordt SH.
    J Clin Invest; 1984 Nov 26; 74(5):1658-68. PubMed ID: 6438155
    [Abstract] [Full Text] [Related]

  • 6. Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats.
    Li SJ, Nussbaum MS, McFadden DW, Gapen CL, Dayal R, Fischer JE.
    Surgery; 1988 Aug 26; 104(2):350-7. PubMed ID: 3135627
    [Abstract] [Full Text] [Related]

  • 7. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels.
    Sax HC, Talamini MA, Brackett K, Fischer JE.
    Surgery; 1986 Oct 26; 100(4):697-704. PubMed ID: 3094186
    [Abstract] [Full Text] [Related]

  • 8. Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide.
    Pappo I, Bercovier H, Berry EM, Haviv Y, Gallily R, Freund HR.
    JPEN J Parenter Enteral Nutr; 1992 Oct 26; 16(6):529-32. PubMed ID: 1494209
    [Abstract] [Full Text] [Related]

  • 9. Fat-based (Intralipid 20%) versus carbohydrate-based total parenteral nutrition: effects on hepatic structure and function in rats.
    Boelhouwer RU, King WW, Kingsnorth AN, Weening JJ, Young VR, Malt RA.
    JPEN J Parenter Enteral Nutr; 1983 Oct 26; 7(6):530-3. PubMed ID: 6418907
    [Abstract] [Full Text] [Related]

  • 10. Pediatric total parenteral nutrition. Liver histopathology.
    Cohen C, Olsen MM.
    Arch Pathol Lab Med; 1981 Mar 26; 105(3):152-6. PubMed ID: 6781446
    [Abstract] [Full Text] [Related]

  • 11. Homocysteine prevents total parenteral nutrition (TPN)-induced cholestasis without changes in hepatic oxidative stress in the rat.
    Belli DC, Albrecht R, La Scala GC, Desjeux JF, Pelissier MA.
    J Pediatr Gastroenterol Nutr; 2003 Feb 26; 36(2):200-5. PubMed ID: 12548054
    [Abstract] [Full Text] [Related]

  • 12. Significance of administration of fat emulsion: hepatic changes in infant rats receiving total parenteral nutrition with and without fat.
    Oshita M, Takehara H, Yamaguchi M, Doi K, Ueda N, Naito S, Hiraoka I, Tashiro S.
    Clin Nutr; 2004 Oct 26; 23(5):1060-8. PubMed ID: 15380896
    [Abstract] [Full Text] [Related]

  • 13. Nutritional efficacy and hepatic changes during intragastric, intravenous, and prehepatic feeding in rats.
    King WW, Boelhouwer RU, Kingsnorth AN, Ross JS, Young VR, Malt RA.
    JPEN J Parenter Enteral Nutr; 1983 Oct 26; 7(5):443-6. PubMed ID: 6417363
    [Abstract] [Full Text] [Related]

  • 14. Effect of L-glutamine on hepatic lipids at different energy levels in rats receiving total parenteral nutrition.
    Yeh SL, Chen WJ, Huang PC.
    JPEN J Parenter Enteral Nutr; 1994 Oct 26; 18(1):40-4. PubMed ID: 8164302
    [Abstract] [Full Text] [Related]

  • 15. Liver Disease in Patients on Total Parenteral Nutrition.
    Mitra A, Ahn J.
    Clin Liver Dis; 2017 Nov 26; 21(4):687-695. PubMed ID: 28987256
    [Abstract] [Full Text] [Related]

  • 16. Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat.
    Pappo I, Becovier H, Berry EM, Freund HR.
    J Surg Res; 1991 Aug 26; 51(2):106-12. PubMed ID: 1907698
    [Abstract] [Full Text] [Related]

  • 17. Liver disease in infants receiving total parenteral nutrition.
    Postuma R, Trevenen CL.
    Pediatrics; 1979 Jan 26; 63(1):110-5. PubMed ID: 108658
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis of hepatic steatosis during total parenteral nutrition.
    Nussbaum MS, Fischer JE.
    Surg Annu; 1991 Jan 26; 23 Pt 2():1-11. PubMed ID: 1907028
    [Abstract] [Full Text] [Related]

  • 19. Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition.
    Cooper A, Betts JM, Pereira GR, Ziegler MM.
    J Pediatr Surg; 1984 Aug 26; 19(4):462-6. PubMed ID: 6434724
    [Abstract] [Full Text] [Related]

  • 20. Metronidazole, cholestasis, and total parenteral nutrition.
    Lancet; 1983 May 21; 1(8334):1161. PubMed ID: 6133174
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.